Cardiotrophin-1 is a key regulator of glucose and lipid metabolism

Cell Metabolism

Volumn 14, Issue 2, 2011, Pages 242-253

  Moreno Aliaga, María J ^a   Pérez Echarri, Nerea ^b   Marcos Gómez, Beatriz ^a   Larequi, Eduardo ^b   Gil Bea, Francisco Javier ^b   Viollet, Benoit ^c,d,e   Gimenez, Ignacio ^f   Martínez, J Alfredo ^a   Prieto, Jesús ^b   Bustos, Matilde ^b  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c INSTITUT COCHIN   (France)

^d CNRS   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTROPHIN 1; GLUCOSE; GLYCOPROTEIN GP 130; INSULIN; LIPID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOGENESIS; BODY WEIGHT; BROWN ADIPOSE TISSUE; CALORIC INTAKE; CONTROLLED STUDY; ENERGY BALANCE; ENERGY EXPENDITURE; FATTY ACID OXIDATION; FOOD INTAKE; GLUCOSE METABOLISM; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; LIPID METABOLISM; LIPOLYSIS; METABOLIC REGULATION; METABOLIC SYNDROME X; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FAMILY; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE, WHITE; ANIMALS; BODY WEIGHT; CYTOKINES; EATING; ENERGY METABOLISM; FATTY ACIDS; GLUCOSE; HYPERCHOLESTEROLEMIA; INSULIN RESISTANCE; LIPID METABOLISM; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OBESITY; OXIDATION-REDUCTION; PHOSPHORYLATION;

MUS;

EID: 79960955885     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2011.05.013     Document Type: Article

References (49)

1. Blüher, S., Moschos, S., Bullen, J., Jr., Kokkotou, E., Maratos-Flier, E., Wiegand, S.J., Sleeman, M.W., and Mantzoros, C.S. (2004). Ciliary neurotrophic factorAx15 alters energy homeostasis, decreases body weight, and improves metabolic control in diet-induced obese and UCP1-DTA mice. Diabetes 53, 2787-2796. (Pubitemid 39425903)
2. Boden, G. (2008). Obesity and free fatty acids. Endocrinol. Metab. Clin. North Am. 37, 635-646, viii-ix.
3. Bonnard, C., Durand, A., Peyrol, S., Chanseaume, E., Chauvin, M.A., Morio, B., Vidal, H., and Rieusset, J. (2008). Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J. Clin. Invest. 118, 789-800.
4. Bordet, T., Schmalbruch, H., Pettmann, B., Hagege, A., Castelnau-Ptakhine, L., Kahn, A., and Haase, G. (1999). Adenoviral cardiotrophin-1 gene transfer protects pmn mice from progressive motor neuronopathy. J. Clin. Invest. 104, 1077-1085.
5. Bustos, M., Beraza, N., Lasarte, J.J., Baixeras, E., Alzuguren, P., Bordet, T., and Prieto, J. (2003). Protection against liver damage by cardiotrophin-1: a hepatocyte survival factor up-regulated in the regenerating liver in rats. Gastroenterology 125, 192-201. (Pubitemid 36799119)
6. Calabrò, P., Limongelli, G., Riegler, L., Maddaloni, V., Palmieri, R., Golia, E., Roselli, T., Masarone, D., Pacileo, G., Golino, P., and Calabrò, R. (2009). Novel insights into the role of cardiotrophin-1 in cardiovascular diseases. J. Mol. Cell. Cardiol. 46, 142-148.
7. Cota, D., Proulx, K., Smith, K.A., Kozma, S.C., Thomas, G., Woods, S.C., and Seeley, R.J. (2006). Hypothalamic mTOR signaling regulates food intake. Science 312, 927-930. (Pubitemid 43727328)
8. Cota, D., Matter, E.K., Woods, S.C., and Seeley, R.J. (2008). The role of hypothalamic mammalian target of rapamycin complex 1 signaling in diet-induced obesity. J. Neurosci. 28, 7202-7208.
9. Crowe, S., Turpin, S.M., Ke, F., Kemp, B.E., and Watt, M.J. (2008). Metabolic remodeling in adipocytes promotes ciliary neurotrophic factor-mediated fat loss in obesity. Endocrinology 149, 2546-2556. (Pubitemid 351574491)
10. Di Gregorio, G.B., Hensley, L., Lu, T., Ranganathan, G., and Kern, P.A. (2004). Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am. J. Physiol. Endocrinol. Metab. 287, E182-E187.
11. Dray, C., Knauf, C., Daviaud, D., Waget, A., Boucher, J., Buléon, M., Cani, P.D., Attané, C., Guigné, C., Carpéné, C., et al. (2008). Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab. 8, 437-445.
12. Febbraio, M.A. (2007). gp130 receptor ligands as potential therapeutic targets for obesity. J. Clin. Invest. 117, 841-849.
13. Febbraio, M.A., Hiscock, N., Sacchetti, M., Fischer, C.P., and Pedersen, B.K. (2004). Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 53, 1643-1648. (Pubitemid 38864744)
14. Hancock, C.R., Han, D.H., Chen, M., Terada, S., Yasuda, T., Wright, D.C., and Holloszy, J.O. (2008). High-fat diets cause insulin resistance despite an increase in muscle mitochondria. Proc. Natl. Acad. Sci. USA 105, 7815-7820.
15. Hardie, D.G. (2008). AMPK: a key regulator of energy balance in the single cell and the whole organism. Int. J. Obes. (Lond.) 32 (Suppl 4), S7-S12.
16. Hiscock, N., Chan, M.H., Bisucci, T., Darby, I.A., and Febbraio, M.A. (2004). Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity. FASEB J. 18, 992-994. (Pubitemid 39561502)
17. Hoehn, K.L., Turner, N., Swarbrick, M.M., Wilks, D., Preston, E., Phua, Y., Joshi, H., Furler, S.M., Larance, M., Hegarty, B.D., et al. (2010). Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity. Cell Metab. 11, 70-76.
18. Iñiguez, M., Berasain, C., Martinez-Ansó, E., Bustos, M., Fortes, P., Pennica, D., Avila, M.A., and Prieto, J. (2006). Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning. J. Exp. Med. 203, 2809-2815.
19. Janoschek, R., Plum, L., Koch, L., Münzberg, H., Diano, S., Shanabrough, M., Müller, W., Horvath, T.L., and Brüning, J.C. (2006). gp130 signaling in proopio-melanocortin neurons mediates the acute anorectic response to centrally applied ciliary neurotrophic factor. Proc. Natl. Acad. Sci. USA 103, 10707-10712.
20. Jocken, J.W., Langin, D., Smit, E., Saris, W.H., Valle, C., Hul, G.B., Holm, C., Arner, P., and Blaak, E.E. (2007). Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. J. Clin. Endocrinol. Metab. 92, 2292-2299.
21. Kristiansen, O.P., and Mandrup-Poulsen, T. (2005). Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes 54 (Suppl 2), S114-S124.
22. Lambert, P.D., Anderson, K.D., Sleeman, M.W., Wong, V., Tan, J., Hijarunguru, A., Corcoran, T.L., Murray, J.D., Thabet, K.E., Yancopoulos, G.D., and Wiegand, S.J. (2001). Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc. Natl. Acad. Sci. USA 98, 4652-4657.
23. Marquès, J.M., Belza, I., Holtmann, B., Pennica, D., Prieto, J., and Bustos, M. (2007). Cardiotrophin-1 is an essential factor in the natural defense of the liver against apoptosis. Hepatology 45, 639-648. (Pubitemid 46450615)
24. Masu, Y., Wolf, E., Holtmann, B., Sendtner, M., Brem, G., and Thoenen, H. (1993). Disruption of the CNTF gene results in motor neuron degeneration. Nature 365, 27-32. (Pubitemid 23305564)
25. Minokoshi, Y., Kim, Y.B., Peroni, O.D., Fryer, L.G., Müller, C., Carling, D., and Kahn, B.B. (2002). Leptin stimulates fatty-acid oxidation by activating AMPactivated protein kinase. Nature 415, 339-343. (Pubitemid 34087557)
26. Natal, C., Fortuño, M.A., Restituto, P., Bazán, A.,Colina, I., Díez, J., and Varo, N. (2008). Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome. Am. J. Physiol. Endocrinol. Metab. 294, E52-E60.
27. Oppenheim, R.W., Wiese, S., Prevette, D., Armanini, M., Wang, S., Houenou, L.J., Holtmann, B., Gotz, R., Pennica, D., and Sendtner, M. (2001). Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons. J. Neurosci. 21, 1283-1291. (Pubitemid 32128773)
28. Pemberton, C.J., Raudsepp, S.D., Yandle, T.G., Cameron, V.A., and Richards, A.M. (2005). Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch. Cardiovasc. Res. 68, 109-117.
29. Pennica, D., Arce, V., Swanson, T.A., Vejsada, R., Pollock, R.A., Armanini, M., Dudley, K., Phillips, H.S., Rosenthal, A., Kato, A.C., and Henderson, C.E. (1996). Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons. Neuron 17, 63-74. (Pubitemid 26251592)
30. Pennica, D., King, K.L., Shaw, K.J., Luis, E., Rullamas, J., Luoh, S.M., Darbonne, W.C., Knutzon, D.S., Yen, R., Chien, K.R., et al. (1995). Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy. Proc. Natl. Acad. Sci. USA 92, 1142-1146.
31. Rong, J.X., Qiu, Y., Hansen, M.K., Zhu, L., Zhang, V., Xie, M., Okamoto, Y., Mattie, M.D., Higashiyama, H., Asano, S., et al. (2007). Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Diabetes 56, 1751-1760. (Pubitemid 47025441)
32. Rouru, J., Cusin, I., Zakrzewska, K.E., Jeanrenaud, B., and Rohner-Jeanrenaud, F. (1999). Effects of intravenously infused leptin on insulin sensitivity and on the expression of uncoupling proteins in brown adipose tissue. Endocrinology 140, 3688-3692. (Pubitemid 30645424)
33. Seale, P., Kajimura, S., Yang, W., Chin, S., Rohas, L.M., Uldry, M., Tavernier, G., Langin, D., and Spiegelman, B.M. (2007). Transcriptional control of brown fat determination by PRDM16. Cell Metab. 6, 38-54. (Pubitemid 47008902)
34. Steensberg, A., van Hall, G., Osada, T., Sacchetti, M., Saltin, B., and Klarlund Pedersen, B. (2000). Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J. Physiol. 529, 237-242.
35. Steinberg, G.R., Watt, M.J., Fam, B.C., Proietto, J., Andrikopoulos, S., Allen, A.M., Febbraio, M.A., and Kemp, B.E. (2006). Ciliary neurotrophic factor suppresses hypothalamic AMP-kinase signaling in leptin-resistant obese mice. Endocrinology 147, 3906-3914. (Pubitemid 44079396)
36. Suárez, E., Bach, D., Cadefau, J., Palacin, M., Zorzano, A., and Gumá, A. (2001). A novel role of neuregulin in skeletal muscle. Neuregulin stimulates glucose uptake, glucose transporter translocation, and transporter expression in muscle cells. J. Biol. Chem. 276, 18257-18264.
37. Talwar, S., Downie, P.F., Squire, I.B., Davies, J.E., Barnett, D.B., and Ng, L.L. (2001). Plasma N-terminal pro BNP and cardiotrophin-1 are elevated in aortic stenosis. Eur. J. Heart Fail. 3, 15-19.
38. Tilg, H., and Moschen, A.R. (2006). Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol. 6, 772-783.
39. Turner, N., Bruce, C.R., Beale, S.M., Hoehn, K.L., So, T., Rolph, M.S., and Cooney, G.J. (2007). Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56, 2085-2092. (Pubitemid 47195821)
40. Villena, J.A., Roy, S., Sarkadi-Nagy, E., Kim, K.H., and Sul, H.S. (2004). Desnutrin, an adipocyte gene encoding a novel patatin domain-containing protein, is induced by fasting and glucocorticoids: ectopic expression of desnutrin increases triglyceride hydrolysis. J. Biol. Chem. 279, 47066-47075.
41. Viollet, B., Andreelli, F., Jørgensen, S.B., Perrin, C., Geloen, A., Flamez, D., Mu, J., Lenzner, C., Baud, O., Bennoun, M., et al. (2003). The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J. Clin. Invest. 111, 91-98.
42. Viollet, B., Athea, Y., Mounier, R., Guigas, B., Zarrinpashneh, E., Horman, S., Lantier, L., Hebrard, S., Devin-Leclerc, J., Beauloye, C., et al. (2009). AMPK: Lessons from transgenic and knockout animals. Front. Biosci. 14, 19-44.
43. Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S.L., Ohlsson, C., and Jansson, J.O. (2002). Interleukin-6- deficient mice develop mature-onset obesity. Nat. Med. 8, 75-79.
44. Watt, M.J., Dzamko, N., Thomas, W.G., Rose-John, S., Ernst, M., Carling, D., Kemp, B.E., Febbraio, M.A., and Steinberg, G.R. (2006). CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. Nat. Med. 12, 541-548.
45. Wilson-Fritch, L., Nicoloro, S., Chouinard, M., Lazar, M.A., Chui, P.C., Leszyk, J., Straubhaar, J., Czech, M.P., and Corvera, S. (2004). Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. J. Clin. Invest. 114, 1281-1289.
46. Wojtaszewski, J.F., Jørgensen, S.B., Hellsten, Y., Hardie, D.G., and Richter, E.A. (2002). Glycogen-dependent effects of 5-aminoimidazole-4- carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 51, 284-292. (Pubitemid 34764782)
47. Wojtaszewski, J.F., and Richter, E.A. (2006). Effects of acute exercise and training on insulin action and sensitivity: focus on molecular mechanisms in muscle. Essays Biochem. 42, 31-46.
48. Wueest, S., Rapold, R.A., Rytka, J.M., Schoenle, E.J., and Konrad, D. (2009). Basal lipolysis, not the degree of insulin resistance, differentiates large from small isolated adipocytes in high-fat fed mice. Diabetologia 52, 541-546.
49. Zvonic, S., Hogan, J.C., Arbour-Reily, P., Mynatt, R.L., and Stephens, J.M. (2004). Effects of cardiotrophin on adipocytes. J. Biol. Chem. 279, 47572-47579.